Comparison of antimicrobial prescription patterns in calves in Switzerland before and after the launch of online guidelines for prudent antimicrobial use by Hubbuch, Alina et al.








Comparison of antimicrobial prescription patterns in calves in Switzerland
before and after the launch of online guidelines for prudent antimicrobial use
Hubbuch, Alina ; Peter, Ruth ; Willi, Barbara ; Hartnack, Sonja ; Müntener, Cedric ; Naegeli,
Hanspeter ; Gerspach, Christian
Abstract: The increasing threat of bacterial resistance promotes the need for antibiotic stewardship
programs to foster responsible antimicrobial use. Therefore, guidelines for prudent use supported by an
online stewardship tool (AntibioticScout.ch) were introduced in Switzerland in December 2016. They
recommend (with decreasing preference) a first, second or third line antimicrobial for treatment. The
objective of this study was to evaluate antimicrobial prescriptions for Swiss calves before (2016) and after
(2018) the launch of these guidelines. Cases of calves with pneumonia, diarrhea and otitis from a university
hospital and eight private practices in Switzerland were included. Data on anamnesis, clinical findings,
diagnostic work-up and treatment were collected. Type and percentages [95% confidence interval] of
antimicrobial prescriptions were compared between 2016 and 2018.
DOI: https://doi.org/10.1186/s12917-020-02704-w






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Hubbuch, Alina; Peter, Ruth; Willi, Barbara; Hartnack, Sonja; Müntener, Cedric; Naegeli, Hanspeter;
Gerspach, Christian (2021). Comparison of antimicrobial prescription patterns in calves in Switzerland
before and after the launch of online guidelines for prudent antimicrobial use. BMC Veterinary Research,
17:2.
DOI: https://doi.org/10.1186/s12917-020-02704-w
RESEARCH ARTICLE Open Access
Comparison of antimicrobial prescription
patterns in calves in Switzerland before
and after the launch of online guidelines
for prudent antimicrobial use
Alina Hubbuch1,2, Ruth Peter1, Barbara Willi2, Sonja Hartnack3, Cedric Müntener1, Hanspeter Naegeli1* and
Christian Gerspach4*
Abstract
Background: The increasing threat of bacterial resistance promotes the need for antibiotic stewardship programs
to foster responsible antimicrobial use. Therefore, guidelines for prudent use supported by an online stewardship
tool (AntibioticScout.ch) were introduced in Switzerland in December 2016. They recommend (with decreasing
preference) a first, second or third line antimicrobial for treatment. The objective of this study was to evaluate
antimicrobial prescriptions for Swiss calves before (2016) and after (2018) the launch of these guidelines. Cases of
calves with pneumonia, diarrhea and otitis from a university hospital and eight private practices in Switzerland were
included. Data on anamnesis, clinical findings, diagnostic work-up and treatment were collected. Type and
percentages [95% confidence interval] of antimicrobial prescriptions were compared between 2016 and 2018.
Results: Of the total number of calves, 88.2% [85.4–90.6] in 2016 (n = 625) and 88.4% [85.7–90.7] in 2018 (n = 655)
were treated with antibiotics. The use of highest priority critically important antimicrobials (HPCIAs) decreased from
52.7% [48.6–56.9] in 2016 to 38.0% [34.2–41.9] in 2018; this decrease was found at the university hospital and in
private practice and in cases with pneumonia and diarrhea. Particularly the use of fluoroquinolones decreased
(2016: 43.1% [39.2–47.2]; 2018: 31.1% [27.6–34.8]). Overall, the number of first line treatments increased from 12.8%
[10.4–15.6] in 2016 to 20.2% [17.3–23.4] in 2018. In cases of pneumonia, first line treatments increased (2016: 15.3%
[11.6–19.9]; 2018: 26.5% [21.8–31.9]) and third line treatments decreased (2016: 43.5% [38.0–49.3]; 2018: 27.9% [23.1–
33.3]); this was seen at the university hospital, whereas in private practice only a decrease of third line treatments
was observed. In cases of diarrhea, more second line at the expense of unlisted antimicrobials were prescribed at
the university hospital in 2018. Antimicrobial treatment of calves with otitis did not change from 2016 to 2018.
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Conclusions: After the introduction of AntibioticScout.ch, more prudent use was observed in the treatment of
calves with pneumonia and diarrhea as less HPCIAs, particularly fluoroquinolones, and more first line antimicrobials
were prescribed. However, the overall frequency of antimicrobial treatment did not change and the use of HPCIAs
was still common in 2018, especially in private practices. Therefore, further antimicrobial stewardship activities are
necessary.
Keywords: Food-producing animals, Cattle, Prescription patterns, Prudent use guidelines, Crowding disease, Calf
scours
Background
Worldwide, large amounts of antimicrobial agents are
used in animals, which foster the development of various
antimicrobial resistances through a selection pressure on
bacteria [1–3]. In 2016, 7′860 tons of veterinary anti-
microbial agents were sold in 30 European countries,
while in Switzerland, around 37.5 tons were sold for
food-producing animals [4, 5]. Antibiotic-resistant
strains, which are frequently detected in calves in
Switzerland, might be a consequence. In the period from
2010 to 2017, an increase in methicillin-resistant
Staphylococcus aureus was measured in slaughter calves
and high resistance rates against tetracycline are com-
mon among respiratory tract pathogens [6–9]. Manage-
ment practices like group treatments, external calf
purchase, crowding and feeding of milk by-products
were found to be risk factors for antimicrobial resis-
tances in Swiss calves [10–12]. The World Health
Organization (WHO) defined Highest Priority Critically
Important Antimicrobials (HPCIAs), which should be
used very prudently in animals to preserve their efficacy
for human medicine [13]. Nevertheless, they are com-
monly prescribed in food-producing animals, especially
for the treatment of calves [12, 14–17]. In a Swiss study,
fluoroquinolones were used in 65% and 3rd or 4th gen-
eration cephalosporins in almost 9% of single animal
treatments in calves on fattening farms [18].
Antimicrobial stewardship measures to optimize and
reduce antimicrobial use are important [19]. They can
include voluntary approaches like improved education,
financial regulations, restrictions, preventive actions and
alternatives to antibiotics [20, 21]. Various actions have
already been implemented. Accordingly, antibiotic sales
from 2008 to 2016 decreased by 45% in Switzerland,
which is mainly due to decreasing sales of premixes [4].
One method to further improve antibiotic prescriptions
are antimicrobial use guidelines. In human medicine,
there are many examples on how such guidelines can re-
duce antimicrobial prescriptions and how compliance
with the guidelines can be increased [22–25]. Mean-
while, in farm animal medicine, several prudent use
guidelines have been issued as well [26–31]. However,
the impact of the guidelines has only been investigated
in few studies. In Germany, the implementation of com-
pulsory prudent use guidelines led to a marked reduc-
tion of antibiotic consumption in pig production [32].
Additionally, a meta-analysis revealed that interventions
restricting antibiotic use in food-producing animals are
associated with reduced antimicrobial resistance and
suggests that these measures also led to a reduction in
antimicrobial resistance in humans, especially in those
with exposure to food-producing animals [33].
In December 2016, national guidelines for prudent
antimicrobial use were introduced in Switzerland and
disseminated through an online decision support tool
known as AntibioticScout.ch [34, 35], which include rec-
ommendations for the most common indications for an-
timicrobials in different animal species. These guidelines
were established by experts of the Vetsuisse Faculty Bern
and Zurich in collaboration with the Swiss Veterinary
Society and under the coordination of the Federal Food
Safety and Veterinary Office. They represent the first na-
tional antimicrobial use guidelines in Switzerland and
were generated on the basis of the latest scientific evi-
dence, pharmacological principles, resistance reports and
the categorization of critical antibiotics by the WHO
[36, 37]. The guidelines recommend a first, second and
sometimes third line antimicrobial if antibiotic treatment
is justified. The preference should always be given to the
first line antimicrobial. If the treatment is not successful,
second or third line antimicrobials can be considered.
Before a change of antimicrobial treatment, diagnosis
and previous therapy (dose, route of application, interval
and duration) should be reconsidered, particularly if a
third line antimicrobial is chosen. Third line antimicro-
bials include HPCIAs; their use is highly restricted and
only justified after pathogen identification and anti-
microbial sensitivity testing.
The aim of this study is to investigate antimicrobial
prescription patterns on the example of common dis-
eases in calves (diarrhea, pneumonia and otitis) in a uni-
versity hospital and eight private practices in Switzerland
in 2016 and 2018. Next, the level of compliance with the
guidelines is evaluated and prescriptions before (2016)
and after (2018) the launch of AntibioticScout.ch are
compared.
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Results
Case characteristics
A total of 625 cases in 2016 were compared to 655 cases
in 2018. Details of case characteristics, diagnostic work-
up and clinical findings in calves with pneumonia, diar-
rhea and otitis are displayed in Table 1. No differences
were found regarding the sex or pretreatment except
that, in the cases with diarrhea, more female and pre-
treated calves were presented in 2018 than in 2016
(Table 1). The age of the calves was not significantly dif-
ferent between 2016, with a range of 1–20 weeks, and
2018, with a range of 1–24 weeks. In addition, there was
no difference in the proportion of calves with pneumo-
nia, where the diagnosis was based on a culture of the
tracheobronchial secretion, between 2016 and 2018
(Table 1). This was also evident when cases presented to
the university hospital (2016: 5.7% [1.6–14.0]; 2018: 2.9%
[0.3–9.9]) and to the private practices (2016: 1.3% [0.3–
3.9]; 2018: 0.0% [0.0–1.6]) were considered separately.
Overall, the proportion of fecal examination in diarrheic
calves was not different between the 2 years (Table 1).
However, more tests were performed in the university
hospital (2016: 55.6% [43.4–67.3]; 2018: 58.3% [46.1–
69.8]) than in private practice (2016: 21.9% [16.6–27.9];
2018: 19.2% [14.3–25.0]).
There were no differences regarding the clinical find-
ings between 2016 and 2018, except that scleral injection
was more frequently described as absent in 2018. In both
years, fever was more often observed in cases with pneu-
monia than in cases with diarrhea (Table 1). In cases
with pneumonia, concurrent diarrhea was common
(2016: 6.1% [3.7–9.5]; 2018: 11.6% [8.1–15.8]) and in
cases with diarrhea concurrent pneumonia was often
listed as an additional diagnosis (2016: 9.8% [6.7–13.8];
2018: 14.9% [11.0–19.4]).
Overall comparison of antibiotic prescriptions
Overall, the proportion of cases treated with antibiotics
did not change between 2016 (88.2% [85.4–90.6]) and
2018 (88.4% [85.7–90.7]). This was also found when the
university hospital (2016: 90.1% [84.0–94.5]; 2018: 90.8%
[84.9–95.0]) and the private practices (2016: 87.6%
[84.3–90.4]: 2018: 87.7% [84.6–90.4]) were analyzed
separately.
More first line antimicrobials were prescribed in 2018
(20.2% [17.3–23.4]) than in 2016 (12.8% [10.4–15.6]),
while for third line antimicrobials, only a tendency to-
wards a reduction was observed (2016: 24.6% [21.4–
28.2]; 2018: 18.5% [15.7–21.6]). For second line antimi-
crobials (2016: 19.5% [16.6–22.8]; 2018: 20.9% [18.0–
24.2]) and unlisted antimicrobials (2016: 31.2% [27.7–
34.9]; 2018: 28.9% [25.5–32.4]) no changes were ob-
served (Fig. 1).
Table 1 Comparison of case characteristics, diagnostic work-up and clinical findings between 2016 and 2018













% [CIa] % [CIa] % [CIa] % [CIa] % [CIa] % [CIa]
Sex Femaleb 9.2 [6.1–13.1] 12.9 [9.3–17.3] 10.5 [7.2–14.5] 18.9 [14.6–23.9] NKc 4.6 [1.0–12.9]
Maleb 3.7 [1.9–6.6] 4.4 [2.4–7.4] 6.1 [3.6–9.4] 7.1 [4.4–10.6] NKc 4.6 [1.0–12.9]
Pretreatment Yesb 16.3 [12.3–21.1] 20.7 [16.3–25.8] 6.4 [3.9–9.8] 14.2 [10.4–18.7] 17.1 [6.6–33.6] 30.8 [19.9–43.4]
Diagnostic testd Yesb 2.4 [1.0–4.8] 0.7 [0.1–2.4] 30.1 [24.9–35.6] 28.7 [23.6–34.2] NAe NAe
Lethargy Yesb 27.6 [22.5–33.0] 23.5 [18.7–28.7] 34.5 [29.1–40.2] 37.2 [31.6–42.9] 8.6 [1.8–23.1] 13.8 [6.5–24.7]
Nob 5.4 [3.1–8.7] 10.9 [7.6–15.0] 9.5 [6.4–13.4] 13.9 [10.1–18.3] 5.7 [0.7–19.2] 6.2 [1.7–15.0]
Inappetence Yesb 17.7 [13.5–22.5] 16.0 [12.0–20.7] 27.4 [22.4–32.8] 23.3 [18.6–28.6] 2.9 [0.1–14.9] 3.1 [0.4–10.7]
Nob 5.8 [3.4–9.1] 9.2 [6.1–13.1] 13.9 [10.1–18.3] 12.2 [8.7–16.4] 5.7 [0.7–19.2] 4.6 [1.0–12.9]
Fever (≥39.5 °C) Yesb 39.8 [34.2–45.6] 41.2 [35.5–47.0] 10.1 [6.9–14.2] 13.9 [10.1–18.3] 28.6 [14.6–46.3] 33.8 [22.6–46.6]
Nob 13.9 [10.2–18.4] 21.1 [16.6–26.2] 37.8 [32.3–43.6] 42.6 [36.9–48.4] 17.1 [6.6–33.6] 13.8 [6.5–24.7]
Abnormal lung soundf Yesb 48.0 [42.1–53.8] 50.3 [44.5–56.2] NAe NAe NAe NAe
Scleral injection Yesb NAe NAe 8.8 [5.8–12.6] 10.1 [6.9–14.2] NAe NAe
Nob NAe NAe 4.1 [2.1–7.0] 12.5 [9.0–16.8] NAe NAe
Signs of sepsisg Yesb NAe NAe 1.7 [0.6–3.9] 2.0 [0.7–4.4] NAe NAe
Nob NAe NAe 4.7 [2.6–7.8] 7.1 [4.4–10.6] NAe NAe
Bloody diarrhea Yesb NAe NAe 11.1 [7.8–15.3] 12.2 [8.7–16.4] NAe NAe
Non-overlapping CIs are written in bold numbers; aCI, 95% confidence interval; bValues not listed were unknown, therefore percentages do not add up to 100%;
cNK, not known; dCulture of bronchoalveolar lavage for pneumonia cases/ Fecal examination for diarrhea cases; eNA, not applicable; fIncluding increased vesicular
sounds; gLeft shift with toxic neutrophils in hematology
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In the university hospital, more first line (2016: 30.3%
[23.3–38.3]; 2018: 51.4% [43.3–59.5]) and second line anti-
microbials (2016: 8.5% [4.9–14.2]; 2018: 21.8% [15.8–29.3])
were prescribed in 2018, while proportions of treatments
with third line antimicrobials (2016: 20.4% [14.6–27.8];
2018: 5.6% [2.9–10.7]) and unlisted antimicrobials (2016:
31.0% [24.0–39.0]; 2018: 12.0% [7.6–18.3]) decreased. On
the other hand, no changes were observed in private prac-
tice with similar proportions of first line (2016: 7.7% [5.6–
10.4]; 2018: 11.5% [9.0–14.6]), second line (2016: 22.8%
[19.3–26.7]; 2018: 20.7% [17.4–24.4]) and third line antimi-
crobials (2016: 25.9% [22.2–30.0]; 2018: 22.0% [18.7–25.8])
in both observation periods and similar use of unlisted anti-
microbials (2016: 31.3% [27.3–35.5]; 2018: 33.5% [29.6–
37.7]). Combination therapies were more often applied in
2018 in private practice (2016: 4.8% [3.0–7.1]: 2018: 9.6%
[7.2–12.4]), but not in the university hospital (2016: 4.2%
[1.6–9.0]; 2018: 0.7% [0.0–3.9]).
The proportions of prescribed antimicrobial classes
overall and separated for the university hospital and pri-
vate practices are shown in Figs. 2, 3 and 4. Taken to-
gether, less fluoroquinolones were prescribed in 2018
(Fig. 2). At the university hospital, there was a marked
decrease in the proportion of prescribed fluoroquino-
lones, while more potentiated sulfonamides were used
(Fig. 3). In the private practices, the decrease of fluoro-
quinolones was accompanied by a more frequent use of
penicillins (Fig. 4). The proportion of HPCIAs per total
number of prescribed antimicrobials was reduced in all
cases (2016: 52.7% [48.6–56.9]; 2018: 38.0% [34.2–41.9],
















































































































































































Fig. 2 Proportions of prescribed antimicrobial classes in 2016 and 2018. Proportions of prescribed antimicrobial classes (dots) per total number of
prescribed antimicrobials in 2016 (n = 582) and 2018 (n = 640) and corresponding 95% confidence intervals (lines); gen., generation;
pot., potentiated







































































































































































Fig. 3 Proportions of prescribed antimicrobial classes in 2016 and 2018; cases presented at the university hospital. Proportions of prescribed
antimicrobial classes (dots) per total number of prescribed antimicrobials in 2016 (n = 134) and 2018 (n = 131) and corresponding 95% confidence
















































































































































































Fig. 4 Proportions of prescribed antimicrobial classes in 2016 and 2018; cases presented in private practice. Proportions of prescribed
antimicrobial classes (dots) per total number of prescribed antimicrobials in 2016 (n = 448) and 2018 (n = 509) and corresponding 95% confidence
intervals (lines); gen., generation; pot., potentiated
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in the university hospital (2016: 41.0% [32.6–49.9]; 2018:
10.7% [6.0–17.3]) and in the private practices (2016:
56.3% [51.5–60.9]; 2018: 45.0% [40.6–49.4]).
In the university hospital, treatment duration did not
significantly change with a range of 1–26 days in 2016 and
a range of 1–24 days in 2018 (median of 6 days in both
years). Treatment duration in private practices could not
be assessed, as data on treatment duration was usually not
recorded in the case histories. Parenteral injection of the
antimicrobials was the most common route of administra-
tion (2016: 98.2% [96.7–99.1]; 2018: 97.6% [96.0–98.7]).
Comparison of antibiotic prescriptions in calves with
pneumonia
Characteristics of the antimicrobial therapy of calves with
pneumonia are displayed in Table 2. More first line anti-
microbials were prescribed in 2018 than in 2016. This
change was evident in the university hospital but not in
private practices, where only a trend was observed. Third
line treatments dropped in 2018. The antimicrobial classes
used in calves with pneumonia are shown in Fig. 5. A
reduction in the use of fluoroquinolones was achieved in
2018, while more amphenicols were used. The proportion
of HPCIAs was reduced from 55.6% [49.8–61.3] in 2016
to 37.7% [32.3–43.4] in 2018. This change was evident in
the university hospital (2016: 43.5% [31.6–56.0]; 2018:
11.8% [5.2–21.9]) and in the private practices (2016: 59.2%
[52.6–65.6]; 2018: 45.0% [38.7–51.5]).
Comparison of antibiotic prescriptions in calves with
diarrhea
In Table 2, antibiotic therapies of calves with diarrhea
are listed. More second line antimicrobials were used in
the university hospital in 2018, while less unlisted anti-
microbials were used. More combination therapies were
applied in the private practices in 2018. Table 3 presents
the therapy of diarrhea cases with respect to whether or
not antimicrobial use was justified. This analysis did not
reveal any changes between the 2 years but, in many
cases, the justification for antimicrobial use could not be
evaluated because of missing data in the records. The
antimicrobial classes prescribed for diarrheic calves are
Table 2 Comparison of antimicrobial therapy between 2016 and 2018
Total University hospital Private practices
2016 2018 2016 2018 2016 2018
Pneumonia n = 294 n = 294 n = 70 n = 70 n = 224 n = 224
% [CIa] % [CIa] % [CIa] % [CIa] % [CIa] % [CIa]
First line antimicrobial 15.3 [11.6–19.9] 26.5 [21.8–31.9] 38.6 [28.0–50.3] 62.9 [51.1–73.2] 8.0 [5.1–12.3] 15.2 [11.1–20.5]
Second line antimicrobial 25.2 [20.6–30.4] 30.3 [25.3–35.8] 15.7 [9.0–26.0] 22.9 [14.6–34.0] 28.1 [22.6–34.3] 32.6 [26.8–39.0]
Third line antimicrobial 43.5 [38.0–49.3] 27.9 [23.1–33.3] 30.0 [20.5–41.5] 7.1 [3.1–15.7] 47.8 [41.3–54.3] 34.4 [28.5–40.8]
Unlisted antimicrobialb 14.3 [10.7–18.7] 13.6 [10.2–18.0] 12.9 [6.9–22.7] 2.9 [0.8–9.8] 14.7 [10.7–20.0] 17.0 [12.6–22.4]
Non-antibiotic therapy 1.7 [0.7–3.9] 1.7 [0.7–3.9] 2.9 [0.8–9.8] 4.3 [1.5–11.9] 1.3 [0.5–3.9] 0.9 [0.2–3.2]
Combination therapy 4.1 [2.1–7.0] 6.1 [3.7–9.5] 1.4 [0.0–7.7] 0.0 [0.0–5.1] 4.9 [2.5–8.6] 8.0 [4.8–12.4]
Diarrhea n = 296 n = 296 n = 72 n = 72 n = 224 n = 224
% [CIa] % [CIa] % [CIa] % [CIa] % [CIa] % [CIa]
First line antimicrobial 8.1 [5.5–11.8] 13.5 [10.1–17.9] 22.2 [14.2–33.1] 40.3 [29.7–51.8] 3.6 [1.8–6.9] 4.9 [2.8–8.6]
Second line antimicrobial 15.2 [11.6–19.7] 14.5 [11.0–19.0] 1.4 [0.2–7.5] 20.8 [13.1–31.6] 19.6 [15.0–25.3] 12.5 [8.8–17.5]
Third line antimicrobial 3.7 [2.1–6.5] 2.0 [0.9–4.4] 11.1 [5.7–20.4] 4.2 [1.4–11.5] 1.3 [0.5–3.9] 1.3 [0.5–3.9]
Unlisted antimicrobialb 49.7 [44.0–55.3] 46.3 [40.7–52.0] 48.6 [37.4–59.9] 20.8 [13.1–31.6] 50.0 [43.5–56.5] 54.5 [47.9–60.9]
Non-antibiotic therapy 23.3 [18.9–28.5] 23.6 [19.2–28.8] 16.7 [9.8–26.9] 13.9 [7.7–23.7] 25.4 [20.2–31.5] 26.8 [21.4–32.9]
Combination therapy 4.4 [2.4–7.4] 8.4 [5.5–12.2] 6.9 [2.3–15.5] 1.4 [0.0–7.5] 3.6 [1.6–6.9] 10.7 [7.0–15.5]
Otitis n = 35 n = 65
% [CIa] % [CIa]
First line antimicrobial 31.4 [18.6–48.0] 21.5 [13.3–33.0]
Second line antimicrobial 8.6 [3.0–22.4] 7.7 [3.3–16.8]
Third line antimicrobial 42.9 [28.0–59.1] 50.8 [38.9–62.5]
Unlisted antimicrobialb 17.1 [8.1–32.7] 18.5 [10.9–29.6]
Non-antibiotic therapy 0.0 [0.0–9.9] 1.5 [0.3–8.2]
Combination therapy 11.4 [3.2–26.7] 10.8 [4.4–20.9]
Non-overlapping CIs are written in bold numbers; aCI, 95% confidence interval; bUnlisted antimicrobial, antimicrobial class not listed in the guidelines
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displayed in Fig. 6, showing a reduction in the use of
fluoroquinolones in 2018 compared to 2016. There was
a reduction in the proportion of prescribed HPCIAs
from 49.8% [43.3–56.3] in 2016 to 34.4% [28.6–40.5] in
2018. This reduction was marked in the university hos-
pital (2016: 38.5% [26.7–51.4]; 2018: 9.5% [3.6–19.6], but
not evident in private practices (2016: 54.0% [46.3–61.5];
2018: 42.3% [35.3–49.6]).
Comparison of antibiotic prescriptions in calves with
otitis
In cases with otitis an insufficient number of affected calves
was found for a sound analysis. Antibiotic therapies and
prescribed antimicrobial classes are displayed in Table 2
and Fig. 7, respectively. No differences were found between
2016 and 2018. The proportion of prescribed HPCIAs did
not change (2016: 48.7% [32.4–65.2]; 2018: 52.1% [39.9–
64.1]).
Discussion
Our results suggest that after the introduction of prudent
use guidelines in Switzerland, less HPCIAs, especially
fluoroquinolones, were used and more first line antimicro-
bials were prescribed to treat calves with pneumonia and
diarrhea in the investigated hospital and private practices.
This indicates an increase of prudent antimicrobial use
and a positive influence of the guidelines on prescription
habits of Swiss veterinarians. The decrease in use of prep-
arations classified as HPCIAs for human medicine by the
WHO aims to minimize resistance development against
these antimicrobial classes. Overall, however, the propor-
tion of antimicrobial prescriptions remained high and al-
most equal in the two study periods.
The decrease of fluoroquinolone prescriptions from
46.7 to 36.9% in the private practices of the present
study and from 31.3 to 8.4% in the investigated univer-
sity hospital indicate a promising trend towards more
prudent use. Previous studies also showed that fluoro-
quinolones are very commonly used in single animal
treatments of calves in Switzerland and other European







































































































































































Fig. 5 Proportions of prescribed antimicrobial classes in 2016 and 2018; cases with pneumonia. Proportions of prescribed antimicrobial classes
(dots) per total number of prescribed antimicrobials in 2016 (n = 302) and 2018 (n = 310) and corresponding 95% confidence intervals (lines); gen.,
generation; pot., potentiated
Table 3 Comparison of justification categories between 2016





% [CIa] % [CIa]
AMUb justified 42.2 [36.5–48.1] 48.3 [42.5–54.2]
a. Antibiotic prescribed a. 83.2 [75.5–89.3] a. 86.0 [79.2–91.2]
b. No antibiotic prescribed b. 16.8 [10.7–24.5] b. 14.0 [8.8–20.8]
AMUb not justified 5.1 [2.9–8.2] 9.1 [6.1–13.0]
a. Antibiotic prescribed a. 73.3 [44.9–92.2] a. 44.4 [25.5–64.7]
b. No antibiotic prescribed b. 26.7 [7.8–55.1] b. 55.6 [35.3–74.5]
Unknown if AMUb justified 52.7 [46.8–58.5] 42.6 [36.9–48.4]
aCI, 95% confidence interval, bAMU, antimicrobial use
















































































































































































Fig. 6 Proportions of prescribed antimicrobial classes in 2016 and 2018; cases with diarrhea. Proportions of prescribed antimicrobial classes (dots)
































































































































Fig. 7 Proportions of prescribed antimicrobial classes in 2016 and 2018; cases with otitis. Proportions of prescribed antimicrobial classes (dots) per
total number of prescribed antimicrobials in 2016 (n = 39) and 2018 (n = 71) and corresponding 95% confidence intervals (lines); pot., potentiated
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reported that fluoroquinolones were prescribed in 65
and 38% of calves during single animal treatments, re-
spectively [12, 18]. In the latter study, the calves were
reared under improved welfare conditions and therefore
HPCIAs might have been less commonly used. In contrast
to other countries in Europe where polymyxins are popu-
lar for the treatment of diarrhea in calves, polymyxins
were rarely prescribed in our study [14]. There is currently
no product containing colistin for oral application in
calves available on the Swiss market. One combination
product containing amoxicillin and colistin is authorized
for parenteral administration but is only rarely used.
The observed increase of first line treatments suggests
that the guidelines had a positive impact on prescription
habits of Swiss veterinarians in 2018. This was also ob-
served in human and small animal medicine after the im-
plementation of prudent use guidelines [22, 25, 38, 39].
With 20.2%, however, the amount of first line prescrip-
tions in 2018 was still quite low and more first line antimi-
crobials were prescribed in the university hospital than in
private practices (51.4% vs. 11.5%).
Notably, also other changes reveal a more prudent hand-
ling of antimicrobials in the university hospital than in pri-
vate practices. While first and second line antimicrobials
increased and treatments with third line or unlisted antimi-
crobials decreased in the university hospital, no overall
changes of antimicrobial treatment were observed in the
private practices. Moreover, encouraging changes in the
treatment of diarrhea cases were only evident in the univer-
sity hospital. Finally, the reduction in the use of fluoroqui-
nolones was more marked at the university with a decrease
from 31.3 to 8.4% compared to 46.7 to 36.9% in the private
practices. It should be mentioned that calves presented to
university hospitals are more often pretreated and typically
suffer from more severe disease symptoms compared to
cases in private practices, which however did not hinder ad-
herence to the guidelines. The higher impact of the guide-
lines at the investigated university is probably due to the
bigger influence of educational actions in this institution
and more boarded specialists promoting prudent anti-
microbial use. Furthermore, while tracking prescriptions for
1 year should have allowed us to observe unbiased prescrip-
tion habits of the veterinarians, it is possible that more time
is needed for the Swiss guidelines to be fully integrated into
the daily routine of the veterinarians. In order to increase
the visibility of the guidelines, they are introduced to every
veterinary student in Switzerland and in continuing educa-
tion events. Further activities to foster antimicrobial stew-
ardship include information campaigns for farmers and
close monitoring of antimicrobial use.
The most marked changes were observed in the treat-
ment of calves with pneumonia with an increase of first
line antimicrobials, especially at the university hospital,
and a decrease of third line antimicrobials and HPCIAs
both at the university hospital and in private practices.
The treatment of pneumonia is quite challenging as anti-
biotic therapy has to be started as early as possible and
resistances in respiratory tract pathogens are quite com-
mon in calves in Switzerland [7–9, 40]. Moreover, the
frequently involved mycoplasmas are susceptible to only
few antibiotics [41]. Therefore, the increased compliance
is a positive development but, with 45.0% of treatments
with HPCIAs in private practices, further improvements
are necessary. Additionally, diagnostic testing was very
rare in cases with pneumonia. Treatments based on sen-
sitivity testing and the identification of resistant bacteria
would be an important step towards more prudent use
and resistance patterns could support evidence-based
recommendations for empirical treatments.
Overall, no increase in compliance with the guidelines
in cases with diarrhea was observed and combination
therapies even increased in private practice. A reduction
of the use of HPCIAs was only noted at the university hos-
pital. This is quite surprising as it is controversially dis-
cussed if antibiotics are necessary to treat diarrhea at all
and the use of HPCIAs is considered obsolete [35, 42, 43].
Concurrent occurrence of pneumonia and diarrhea was
common in this study and it was often not distinguishable
for which disease the calf was treated. This could be a rea-
son for the frequent prescription of broad-spectrum anti-
biotics, combination therapies or unlisted antimicrobials.
Also, veterinarians could have been tempted to prescribe
combination therapies as alternative to the “potent”
fluoroquinolones.
In Germany, the introduction of compulsory prudent
use guidelines led to a marked reduction of antibiotic con-
sumption in pigs and similar changes were observed in
small animal medicine [32, 39, 44]. Furthermore, mortality
was not higher after a reduction of antimicrobial use by
46% in a Belgian veterinary practice [45]. Particularly in
calves with diarrhea, a decrease of antibiotic treatments is
desirable, but was not seen in this study. Responses to
questionnaires indicate that farm animal veterinarians are
aware of antimicrobial resistance, but believe that the use
of antibiotics in food producing animals has no relevant
public health impact or that other veterinarians or human
medicine mainly contribute to this problem [46–48].
Therefore, some veterinarians may underestimate their
potential to combat the development, selection and spread
of antimicrobial resistance. Other reasons for not follow-
ing prudent use guidelines are for example the owners’ re-
quest to use a “potent” broad spectrum antibiotic with a
short withdrawal period and easy administration. Further,
farmers are often reluctant to carry the costs of antibiotic
sensitivity testing [49].
For the calves with diarrhea, we tried to assess whether
antimicrobial use was justified or not. However, in about
50% of the cases it was not possible to evaluate the
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necessity for antimicrobial use due to missing informa-
tion in the records. In the private practices, frequently
no information on clinical findings were noted. Criteria
whether to prescribe antibiotics or not in diarrheic
calves are difficult to define but, due to the risk of
bacteremia, it has been recommended to treat all diar-
rheic calves with signs of systemic illness with antibiotics
[43]. In our study, calves with findings indicating a sys-
temic disease such as inappetence, lethargy, fever,
engorged scleral blood vessels or signs of sepsis in the
hematologic analysis, were judged as cases necessitating
antimicrobial use. With these criteria, antimicrobial use
was justified in 89.3% (2016) and 84.1% (2018) of the
cases where sufficient data were recorded in the case
history. It is suggested by the AntibioticScout.ch guide-
lines to differentiate lethargy due to a possible septi-
cemia from lethargy due to blood acidosis and to assess
the mental status after correcting the blood pH with bi-
carbonate [35]. However, due to the retrospective nature
of this study it was not possible to differentiate the
causes of lethargy. In a study from Canada, the imple-
mentation of a treatment algorithm for diarrheic calves
in two farms led to reduced antimicrobial treatment
rates without increasing the risk of mortality [50]. In an
experimental study, calves showed less days with diar-
rhea if they were assigned to a targeted therapy group,
where diarrhea was only treated with antimicrobials if
fever was present [51]. These findings confirm that mon-
itoring the general health status of the calves is a pre-
requisite to achieve prudent antimicrobial use. The high
proportion of cases with justification for antimicrobial
use in our study suggests that the criteria were not strict
enough as fever was only present in 21.1% (2016) and
24.6% (2018) of the calves in which body temperature
was recorded. In calves with pneumonia, instead, it is
generally recognized that antimicrobial treatment as
early as possible in the course of the disease is necessary
in the vast majority of cases [40, 52]. A study that used
continuous monitoring of body temperature of the ani-
mals found that 25.7% of the calves with fever and a pre-
sumptive (not confirmed) diagnosis of pneumonia based
on the exclusion of other calf diseases did not require
antibiotics after an initial treatment with non-steroidal
anti-inflammatory drugs. This study suggests that some
cases of pneumonia may resolve without antibiotic treat-
ment [53]. Similar to the treatment recommendations
for pneumonia, an early diagnosis and thus a prompt
start of treatment is thought to improve the prognosis in
cases of otitis [54].
Pneumonia and diarrhea are common diseases in
calves and a high frequency of otitis cases was suggested
in a Swiss study, where 22.3% of single animal treat-
ments were prescribed for otitis [55]. In the present re-
port, a small number of calves with otitis were available
and the cases were very unequally distributed between
the different private practices. This is in line with an-
other Swiss study where otitis was only diagnosed in
1.2% of diseased calves [56]. The reason for this discrep-
ancy could be that beef calves were investigated in the
first study, whereas the second study focused on dairy
calves. Unfortunately, our results indicate that HPCIAs
are commonly used to treat otitis. Mycoplasma bovis is
mainly found in otitis in calves and the chosen antibiotic
has to cover this pathogen [41, 54, 57]. Tetracyclines are
suggested as first line antimicrobials by the guidelines,
but their efficacy may be limited by resistances [7–9].
Digestive disorders and respiratory diseases are consid-
ered the main causes of death in Swiss veal calves and
antibiotic treatments should be possible in justified cases
[58]. Other treatment options like phytotherapeutics and
probiotics may be considered [59, 60]. In addition, im-
proved management without transport of animals and
crowding as well as prevention by vaccination can re-
duce the number of diseased calves and, therefore, con-
stitute effective ways to reduce antimicrobial
prescriptions [18, 40, 42, 61, 62].
Although only a small sample of veterinary practices
was included, our results are reflected by the national
antimicrobial sales data. Sales of parenterally adminis-
tered preparations in Switzerland, which was the main
application route for single animal treatment in our
study, decreased only by 2.4% between 2016 and 2018,
in contrast to the overall sales of antimicrobials that de-
creased by 15.6% [63]. National sales of HPCIAs includ-
ing fluoroquinolones were reduced between 2016 and
2018 [63], which was also evident in our study. However,
such sales data do not indicate the species or disease for
which an antibiotic was used. Our study investigated the
prescription patterns before and after the implementa-
tion of prudent use guidelines in Switzerland. The true
impact of the guidelines could not be unequivocally
assessed due to the lack of a control group without ac-
cess to those guidelines. Since its launch in December
2016, AntibioticScout.ch has been accessed over 275′000
times (as of July 2020), suggesting that the observed shift
to more prudent use of antibiotics is largely due to the
impact of this new antimicrobial stewardship tool, al-
though we cannot completely rule out that the general
awareness on antimicrobial resistance and other educa-
tional activities may have contributed to treatment
changes. The private practices participated on a volun-
tary basis and, therefore, were perhaps more inclined to
prudent principles than other practices. Moreover, this
study revealed that, especially in private practices, the in-
formation available in the medical records was often lim-
ited. For example, information about treatment duration
and justification for antimicrobial use in cases of diar-
rhea were scarce. The documentation of case histories
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by farm animal practitioners seems to be poor and elec-
tronical records were sometimes used for billing pur-
poses only. Further, follow-up treatments are often
allocated to the farmers. Collectively, these prescription
habits are not consistent with prudent antimicrobial use
as complete medical records are necessary to ensure the
compliance with guidelines.
Our data was presented with 95% confidence intervals
(CI) and a statistical difference was assumed if CIs were
non-overlapping. As a note of caution, this approach
does not adjust for multiple comparisons. If restricting
our analysis to the overall comparisons of prescribed
HPCIAs, fluoroquinolones and first line antimicrobials
of significant differences between 2016 and 2018 by
Fisher’s exact tests, all p values are below 0.001. The sig-
nificance level of a Bonferroni adjusted p value for mul-
tiple comparisons would be equal to 0.016.
Conclusions
In conclusion, we observed a trend towards more pru-
dent antimicrobial use in calves with pneumonia and
diarrhea in the investigated university hospital and
private practices. These changes were more distinct in
the university hospitals. In view of the common poor
documentation in medical records, the study underlines
the need to better document the data that justify the use
and choice of antimicrobials by veterinarians. There is
still a large potential to further reduce the prescription
of antimicrobials in diseased calves and to handle HPCI
As more prudently, especially in private practices.
Therefore, additional antimicrobial stewardship activities
to promote prudent use are necessary.
Methods
Electronic records of the university teaching hospital of
the Vetsuisse Faculty Zurich and eight private veterinary
practices in Switzerland were studied for calves with
pneumonia, diarrhea and otitis. Cases with otitis were
only searched in the private practices as this condition is
rarely presented to university hospitals. The private
practices participated voluntarily and only practices
using OblonData® (Amacker&Partner Informatik AG,
Zurich, Switzerland) or Diana Suisse® (Diana Software
AG, Zurich, Switzerland) were able to participate
Table 4 Recommendations for antimicrobial choice
Disease Route of
administration









3rd or 4th generation
cephalosporinb
Diarrhea
caused by enterotoxigenic Escherichia
coli
c
oral Amoxicillin Sulfonamide +
trimethoprim
Neomycin




caused by Coccidia oral Sulfonamide
with suspicion of Salmonellosis parenteral Sulfonamide +
trimethoprim
Aminoglycoside Fluoroquinoloneb
Otitis parenteral Tetracycline Florfenicol Fluoroquinoloneb
Macrolideb
Based on the guidelines for prudent antimicrobial use available on AntibioticScout.ch [34, 35]; a3rd or 4th generation cephalosporin excluded; bhighly restricted
use, i.e. prescription only justified after pathogen identification and antimicrobial sensitivity testing; cas calves with diarrhea, regardless of etiology, often have
coliform bacterial overgrowth of the small intestines [43], cases with unknown cause of diarrhea were judged using the guidelines for diarrhea caused by
enterotoxigenic Escherichia coli
Table 5 Evaluation criteria to assess whether antimicrobial treatment is justified or not in calves with diarrhea
Judgement Criteria
AMUa is justified if at least one of the following criteria is fulfilledb: Lethargy and/or inappetencec, fever (≥39.5 °C), scleral injection, signs of
sepsis in hematologyd
Suspicion of Salmonellosis is given if at least two of the following
criteria are fulfillede:
Fever (≥39.5 °C), hematochezia, signs of sepsis in hematologyd
Based on the online guidelines for prudent antimicrobial use available on AntibioticScout.ch [34, 35]; aAMU, antimicrobial use; bAMU was defined as not justified if
neither lethargy/inappetence nor fever were present; cAccording to the original guidelines, AMU is only justified in lethargic calves, which don’t improve after
correction of the blood acidosis with bicarbonate infusions; dLeft shift with toxic neutrophils; eIn severe and acute cases, special guideline recommendations can
be followed before results of bacteriological culture are available
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because of practical reasons. Cases from 2016 were eval-
uated as base line and cases from 2018 were analyzed as
follow-up after introduction of the AntibioticScout.ch
tool in December 2016. Records were searched using
predefined terms. Calves were defined as cattle under 6
months of age or if the age was unknown but the animal
was declared as “calf” in the records, the case was also
included. Further, a diagnosis of pneumonia (or if they
had a clear history of respiratory signs like coughing or
nasal discharge), diarrhea or otitis was necessary for in-
clusion. Calves were excluded if the animal died or was
euthanized before treatment was possible or if the medi-
cation was not identifiable. In the private practices, 28
cases per indication and practice were selected. In all
but one private practice, less than 28 cases with otitis
were found, therefore all cases matching inclusion cri-
teria were included. In the university hospital, all cases
found in 2016 were selected for evaluation and the same
amount of cases, chosen via random selection, was col-
lected in 2018. Only the initial treatment was evaluated
and group treatments were rated as one case.
Data on age, sex, pretreatment, clinical findings, add-
itional diseases, diagnostic work-up (fecal examination
and blood hematology for diarrhea, culture of bronchoal-
veolar lavage for pneumonia) and antibiotic therapy (anti-
microbial class, route of administration, treatment
duration) were collected. Subsequently, antimicrobial
treatment was compared to the consensus guidelines pub-
lished in AntibioticScout.ch. Antimicrobials were graded
as first, second or third line antimicrobial as displayed in
Table 4. Antimicrobials not listed in the guidelines were
classified as unlisted antimicrobial. Additionally, in cases
with diarrhea, clinical findings and hematological results
were considered to assess if antimicrobial treatment was
justified or not. To facilitate equal judgement and because
of limited information in the records, small adjustments of
the original guidelines were made (details of the judge-
ment criteria are displayed in Table 5). In cases with pneu-
monia or otitis, antimicrobial treatment was always
considered to be justified.
Highest Priority Critically Important Antimicrobials
(HPCIAs) included quinolones, third or higher gener-
ation cephalosporins, macrolides, ketolides, glycopep-
tides and polymyxins as proposed by the WHO [13]
(ketolids and glycopeptides have no marketing
authorization for veterinary medicine in Switzerland).
IBM SPSS Statistics 23® (IBM, New York, USA) and
the software R version 3.6.1 (R Foundation for Statistical
Computing, Vienna, Austria [64]) were used for statis-
tical analysis. Interval data (age, treatment duration)
were compared with a Mann Whitney U Test. The com-
mand binom.test() [64] was used to estimate proportions
and Clopper Pearson 95% CIs to compare categorical
parameters (case characteristics, diagnostic work-up,
clinical findings, justification categories, prescribed
HPCIAs and combination therapies). 95% CIs for multi-
nomial proportions were estimated with the command
MultinomCI() in the package DescTools [65] for the
prescribed antimicrobial classes and to compare first,
second, third line antimicrobial treatments, treatments
with unlisted antimicrobials and non-antibiotic therap-
ies. With the aim to describe the magnitude of the dif-
ferences in the investigated parameters, we decided to
present 95% CIs, assuming that non-overlapping CIs in-
dicate statistical differences with p smaller as 0.05 [66].
The absolute numbers used to calculate proportions and
95% CIs are available in Additional file 1, Additional file 2
and Additional file 3.
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